Cargando…

Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis

BACKGROUND: Cervical cancer is a major concern to women’s health, being the fourth most common cancer worldwide. A great percentage of these cancer is consequence of an HPV infection, namely from specific genotypes such as 16/18. Portuguese screening program subjects women to a reflex cytology triag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Figueiredo, Daniel, Ribeiro, Inês, Penedones, Ana, Mendes, Diogo, Alves, Carlos, Batel-Marques, Francisco, da Silva, Daniel Pereira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999620/ https://www.ncbi.nlm.nih.gov/pubmed/36894908 http://dx.doi.org/10.1186/s12905-023-02219-0

Ejemplares similares

A systematic review of observational studies evaluating costs of adverse drug reactions
por: Batel Marques, Francisco, et al.
Publicado: (2016)

Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review
por: Batel-Marques, Francisco, et al.
Publicado: (2019)

Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses
por: Alves, Carlos, et al.
Publicado: (2020)

Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
por: Alves, Carlos, et al.
Publicado: (2023)

Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients
por: Mendes, Diogo, et al.
Publicado: (2020)

A comparison between two recommendations to conduct and report systematic reviews on drug’s safety
por: Penedones, Ana, et al.
Publicado: (2019)

Recommendations to conduct and report systematic reviews in medical literature: a scoping review
por: Penedones, Ana, et al.
Publicado: (2019)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows
por: Huijsmans, Cornelis Johannes Jacobus, et al.
Publicado: (2016)

Number needed to treat (NNT) in clinical literature: an appraisal
por: Mendes, Diogo, et al.
Publicado: (2017)

Evaluation of Aptima Zika Virus Assay
por: Ren, Ping, et al.
Publicado: (2017)

Performance of Aptima HPV E6/E7 mRNA Test for Detection of Cervical Lesions in a Large Chinese Population
por: Yang, Zhujuan, et al.
Publicado: (2022)

Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation
por: Weston, Georgie, et al.
Publicado: (2020)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
por: Pista, Angela, et al.
Publicado: (2019)

Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study
por: Schwebke, Jane R., et al.
Publicado: (2020)

HPV infection and cervical neoplasia: associated risk factors
por: Ribeiro, Andrea Alves, et al.
Publicado: (2015)

HPV distribution in cervical cancer in Portugal. A retrospective study from 1928 to 2005
por: Félix, Ana, et al.
Publicado: (2016)

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
por: Simms, Kate T., et al.
Publicado: (2017)

The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologies
por: Guo, Yanli, et al.
Publicado: (2014)

Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness
por: Yazdanpanah, Yazdan, et al.
Publicado: (2013)

The cost of cancer treatment in Portugal
por: Lopes, José Machado, et al.
Publicado: (2017)

P02-12 The implementation cost of a walking football exercise program for patients with type 2 diabetes: a case study of SWEET-Football (Portugal)
por: Barbosa, Ana, et al.
Publicado: (2022)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

Burden of Disease and Cost of Illness of Inflammatory Bowel Diseases in Portugal
por: Magro, Fernando, et al.
Publicado: (2022)

Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy
por: Bakkour, Sonia, et al.
Publicado: (2020)

The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review
por: Mendes, Diogo, et al.
Publicado: (2015)

APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database
por: Khader, Samer N., et al.
Publicado: (2010)

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
por: Chrysostomou, Andreas C., et al.
Publicado: (2018)

Oncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention
por: Silva, Jani, et al.
Publicado: (2011)

Validation of the Hologic Aptima Unisex and Multitest Specimen Collection Kits Used for Endocervical and Male Urethral Swab Specimens (Aptima Swabs) for Collection of Samples from SARS-CoV-2-Infected Patients
por: Avaniss-Aghajani, E., et al.
Publicado: (2020)

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador
por: Campos, Nicole G., et al.
Publicado: (2019)

High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program
por: Sousa, Hugo, et al.
Publicado: (2019)

Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness
por: Neves, Manuel, et al.
Publicado: (2021)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
por: Zeferino, Luiz Carlos, et al.
Publicado: (2018)

HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
por: Amaro-Filho, Sérgio Menezes, et al.
Publicado: (2018)

Inequities in Screening and HPV Vaccination Programs and Their Impact on Cervical Cancer Statistics in Romania
por: Simion, Laurentiu, et al.
Publicado: (2023)

Diversity and Bioactive Potential of Actinobacteria Isolated from a Coastal Marine Sediment in Northern Portugal
por: Ribeiro, Inês, et al.
Publicado: (2020)

Costs of the Smoking Cessation Program in Brazil
por: Mendes, Andréa Cristina Rosa, et al.
Publicado: (2016)

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p6dc43q100iah297kv2fjosnhg